AAB.TO Stock News Aberdeen International Inc. (AAB.TO) 0.16 08/01/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aberdeen International Inc. (AAB.TO) 0.16 $AAB.TO

Aberdeen Announces AGM Results
Marketwire - Mon Jul 07, 4:06PM CDT
ABERDEEN INTERNATIONAL INC. ("Aberdeen", or the "Company" (TSX: AAB) reports, in accordance with the policies of the Toronto Stock Exchange, that the nominees listed in the management proxy circular dated May 30, 2014 for the 2014 Annual and Special Meeting of shareholders (the "Meeting" were elected as directors of the Company.

Aberdeen Reports Shareholders' Equity of $0.53 Per Share and 2015 First Quarter Financial Results
Marketwire - Wed Jun 18, 1:28AM CDT
ABERDEEN INTERNATIONAL INC. ("Aberdeen", or the "Company" (TSX: AAB) has released its financial results for the first quarter of 2015, ended April 30, 2014. For more information please see the Company's Condensed Interim Financial Statements and Management's Discussion and Analysis ("MD&A" posted on SEDAR at www.sedar.com.

Aberdeen International Reports Value of Investment Portfolio and Cash of $0.50 Per Share for First Quarter Ending April 30, 2014
Marketwire - Mon May 26, 4:03PM CDT
ABERDEEN INTERNATIONAL INC. ("Aberdeen", or the "Company" (TSX: AAB) today announces that the value of its investment portfolio as at April 30, 2014, the end of its 2015 first fiscal quarter, was approximately $44.0 million including a cash balance of $0.3 million. This equates to a value of $0.50 per basic share outstanding based on Aberdeen's investment portfolio alone. This report of the portfolio value is not equivalent to the net asset value that has been previously reported by Aberdeen as it does not include assets and liabilities of the Company that are not treated as investments. Rather, this report refers only to the cash, equity investments (private and public), option-type investments (for example, warrants) and corporate debt/loans receivable of the Company.

Aberdeen International Reports Value of Investment Portfolio and Cash of $0.54 Per Share for Fourth Quarter Ending January 31, 2014
Marketwire - Tue Feb 18, 4:02PM CST
ABERDEEN INTERNATIONAL INC. ("Aberdeen", or the "Company" (TSX: AAB) today announces that the value of its investment portfolio as at January 31, 2014, the end of its 2014 fourth fiscal quarter, was approximately $46.8 million including a cash balance of $0.7 million. This equates to a value of $0.54 per basic share outstanding based on Aberdeen's investment portfolio alone. This report of the portfolio value is not equivalent to the net asset value that has been previously reported by Aberdeen as it does not include assets and liabilities of the Company that are not treated as investments. Rather, this report refers only to the cash, equity investments (private and public), option-type investments (for example, warrants) and corporate debt/loans receivable of the Company.

Small Political Parties Denied Funding
by Anthony Langat - All Africa Global Media - Tue Feb 04, 7:01AM CST
THE High Court in Nairobi has declared that small political parties in the country cannot access any funding through the Political Parties Fund.

Canadian Metals Files its Langis Project NI 43-101 Technical Report on SEDAR
Marketwire Canada - Thu Dec 19, 8:30AM CST
Canadians Metals Inc. (the "Corporation" (CNSX:CME) is pleased to announce the filing of the NI 43-101 technical report for the Langis project on SEDAR (www.sedar.com). The report was prepared by GENIVAR Inc. in conjunction with Etienne Forbes, P.Geo.

Aberdeen Reports Shareholders' Equity of $0.58 Per Share and Financial Results for Third Quarter Ended October 31, 2013
Marketwire - Tue Dec 17, 6:01AM CST
ABERDEEN INTERNATIONAL INC. ("Aberdeen", or the "Company" (TSX: AAB) has released its financial results for the third quarter of 2014, ended October 31, 2013. For more information please see the Company's Condensed Interim Financial Statements and Management's Discussion and Analysis ("MD&A" posted on SEDAR at www.sedar.com.

Aberdeen Reports Shareholder Equity of $0.61 Per Share for Second Quarter Ended July 31, 2013
Marketwire - Tue Sep 17, 7:03AM CDT
ABERDEEN INTERNATIONAL INC. ("Aberdeen", or the "Company" (TSX: AAB) is pleased to announce that it has released its financial results for the second quarter of 2014, ended July 31, 2013. For more information please see the Company's Condensed Interim Financial Statements and Management's Discussion and Analysis ("MD&A" posted under the Company's profile on SEDAR at www.sedar.com.

Aberdeen International Reports Value of Investment Portfolio and Cash of $0.59 Per Share for Second Quarter Ending July 31, 2013
Marketwire - Mon Aug 19, 6:31AM CDT
ABERDEEN INTERNATIONAL INC. ("Aberdeen", or the "Company" (TSX: AAB) announces that the value of its investment portfolio as at July 31, 2013, the end of its 2014 second fiscal quarter, was approximately $50.7 million including a cash balance of $1.9 million. This equates to a value of $0.59 per basic share outstanding based on Aberdeen's investment portfolio alone. This report of the portfolio value is not equivalent to the net asset value that has been previously reported by Aberdeen as it does not include assets and liabilities of the Company that are not treated as investments. Rather, this report refers only to the cash, equity investments (private and public), option-type investments (for example, warrants) and corporate debt/loans receivable of the Company.

Aberdeen Reports Shareholders' Equity of $0.64 Per Share and First Quarter 2014 Financial Results
Marketwire - Mon Jun 17, 6:01AM CDT
ABERDEEN INTERNATIONAL INC. ("Aberdeen", or the"Company" (TSX: AAB) released its financial results for the first quarter of 2014, ended April 30, 2013. For more information please see the Company's Condensed Interim Financial Statements and Management's Discussion and Analysis ("MD&A" posted on SEDAR at www.sedar.com.

Aberdeen International Reports Value of Investment Portfolio and Cash of $0.65 Per Share for First Quarter Ending April 30, 2013
Marketwire - Tue May 28, 4:10PM CDT
ABERDEEN INTERNATIONAL INC. ("Aberdeen", or the "Company" (TSX: AAB) today announces that the value of its investment portfolio as at April 30, 2013, the end of its 2014 first fiscal quarter, was approximately $55.4 million including a cash balance of $3.7 million. This equates to a value of $0.65 per basic share outstanding based on Aberdeen's investment portfolio alone. This report of the portfolio value is not equivalent to the net asset value that has been previously reported by Aberdeen as it does not include assets and liabilities of the Company that are not treated as investments. Rather, this report refers only to the cash, equity investments (private and public), option-type investments (for example, warrants) and corporate debt/loans receivable of the Company.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Health Net Invests $3 Million in Stockton Housing

Updated Category News Views 145

Putting a Roof Over Stockton's Head The talk of the town in Stockton is Health Net stepping up with a $3 million investment. This isn't just dropping loose change in a jar; it's about tackling a mammoth issue—making affordable housing more than just a pipe dream for 75 families. Community-driven, they say. What a cozy way to paint a picture of bridging that brutal gap...

Continue Reading
Partner Joins Yardi ICN, Boosting Data Quality for Clients

Updated Category News Views 91

Strategic Alliances in Real Estate Data When Partner Engineering and Science, Inc. says they're hooking up with the Yardi Independent Consultant Network (ICN), that's not just some boardroom handshake. It's a play that could shake up data services in the real estate game. Look, there's plenty of chatter about digitizing property management, but without killer data, those...

Continue Reading
Dyania, NVIDIA Team Up: AI Transforming Patient Care

Updated Category News Views 61

Revving up efficiency in healthcare usually sounds like pie-in-the-sky talk, but every now and again, an innovation comes along that really stirs the pot. Enter Dyania Health's Synapsis AI, a clinical reasoning AI, teaming with NVIDIA's robust computing infrastructure. They're setting out to make sense of massive amounts of patient data, securely tucked behind a...

Continue Reading
D-Wave's 9.5% Drop: Fraud Lawsuit Raises Investor Ire

Updated Category News Views 101

Shockwaves from D-Wave's Earnings Call August wasn't exactly a banner month for D-Wave Quantum, Inc. as their stock went down like a lead balloon following a lackluster earnings report. If you've ever had any skin in the game, you'd know a 9.5% drop isn't just peanuts—it's the equivalent of watching your prized racehorse stumble at the first hurdle. The financials spoke...

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 70

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
PenFed Fuels Aggie Spirit with Blackout Game Activation

Updated Category News Views 156

A Different Kind of Game Day Experience Ah, there's nothing quite like the vibrancy of a Texas A&M game day, especially when it's a blackout event. On November 14, fans aren't just getting the good old college football thrills; they're diving headfirst into an extravaganza, courtesy of PenFed Credit Union. You might know them as the go-to credit union for military folks,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 46

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Fly-E Faces Revenue Drop Amid Retail Restructuring

Updated Category News Views 215

Downturn Despite Strategic Restructuring Today, we're diving into Fly-E Group, Inc. (NASDAQ:FLYE) and the latest shakeup in their financials—spoiler alert, it's riding a downward slope. Quarter two of fiscal 2027 didn't exactly shine a light on profitability. Net revenues slid, dropping to $2.6 million this quarter, down from $3.9 million the previous year. Tack that up...

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
FiEE Rockets to Profitability with 382% Revenue Surge

Updated Category News Views 170

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Continue Reading

Top 5 Most Recently Viewed Articles

Cresilon Expands Reach with New VETIGEL Deal for Veterinarians

Updated Category News Views 267

Cresilon Partners with McCarthy Vet to Distribute VETIGEL Cresilon Inc., an innovative biotechnology firm known for its advanced hemostatic products, has announced a transformative agreement with McCarthy Vet. This collaboration marks a significant step forward as it allows for the distribution of VETIGEL, a groundbreaking hemostatic gel, directly to veterinary surgeons....

Continue Reading
Absci's Upcoming Financial Report and Business Highlights

Updated Category News Views 192

Absci Corporation's Upcoming Financial Reports Absci Corporation (Nasdaq: ABSI), recognized as a pioneer in data-driven generative AI for drug discovery, is gearing up to release important business updates along with financial results for the first quarter of 2025. This report is scheduled to be unveiled subsequent to market close. Key Highlights of the Upcoming Report...

Continue Reading
Upcoming Q2 2025 Results Announcement by Borregaard ASA

Updated Category News Views 186

Borregaard ASA's Second Quarter Results Announcement Borregaard ASA, a renowned name in biochemistry, is set to present its Q2 2025 results. This event will take place on Wednesday, coinciding with July 16, 2025, at 07:00 CEST. As anticipated, a comprehensive stock exchange announcement will follow shortly thereafter. What to Expect from the Presentation The presentation...

Continue Reading
JP Conte's Lupine Crest Pours $14M into Orizon Again

Updated Category News Views 29

JP Conte's Bet on Brazilian Waste-to-Energy Giant Here's the scoop, folks. Lupine Crest Capital, helmed by none other than JP Conte, just doubled down on their investment in Brazil. This isn't some negligible penny-ante increase, but a hefty infusion of R$70 million—think roughly $14 million in USD—into Orizon Valorização de Resíduos S.A., the notable...

Continue Reading
Hedge Funds Shift Strategies Amid Volatile U.S. Equity Markets

Updated Category News Views 121

Hedge funds adjusted their playbooks back then in 2023, net selling equities amid a flurry of options expiry and index rebalancing. The desks were abuzz as they noted slight selling pressure from these funds, yet after the dust settled on that chaotic week, buying picked up noticeably—especially Thursday when it seemed traders found some footing again. Macro Products...

Continue Reading